No.47
SARS: a silent war - Participation
in an international symposium in Taiwan - |
|
By Fumio KOBUNE, DVM. Ph.D.,Invited
Researcher, BMSA/Institute of Medical Science, University
of Tokyo /National Institute of Infectious Diseases
|
 |
|
-Introduction
-In November 2002, a worker in an agricultural cooperative
in a community in Guangdong Province, China (patient No. 1) developed
fever and pneumonia. Later on a cook dealing with wild animals
was infected (patient No. 2). Afterward cases of pneumonia increased
in the neighboring areas. At the beginning, the Chinese authorities
had thought this was a kind of pneumonia caused by Chlamydia,
and they reported to the WHO that this outbreak had come to an
end. However the situation changed completely after a few months.
In fact 305 cases of atypical pneumonia (5 fatalities) had been
occurring in the meantime. This was officially announced on February
14 after a blank of approximately three months. Now SARS has spread
to 31 countries (regions) and affected 8,141 people, of whom 696
have passed away (as of May 25, 2003). SARS has been definitely
identified as a global new emerging infectious disease.
-Symposium
An International Symposium on Severe Acute Respiratory
Syndrome (SARS) Outbreaks was organized under the auspices of
Taiwan's Ministry of Health in the International Conference Hall
of Taipei on April 20~21, 2003. Three hundred people from thirteen
countries including Japan, Australia, Hong Kong, Malaysia, India,
The Philippines, Indonesia, Vietnam, Thailand, the USA, Mali and
Russia participated in the symposium to report on the current
situation of the SARS epidemic.
Before the opening address (Dr. Shing-Jer Twu, MD,
MPH, PhD, Minister of Health), the death of the clinical doctor
Dr. Carlo Urbani who himself contracted SARS was mourned over,
and all the participants rose to pay a silent tribute. The symposium
progressed in a solemn atmosphere. This article written by the
author who had the opportunity to attend the symposium summarizes
the proceedings.
Patient No. 0 in Hong Kong
A doctor (64 years of age) in Guangdong Province,
China, ran a fever on February 21, 2003. However he traveled to
Hong Kong in order to attend the marriage of a relative and he
put up on the 9th floor of the Metropolitan (MP)Hotel. As a result,
he became a superspreader (See Note) and spread the infection
to other people. He is called Patient Number Zero. Pneumonia infected
87 health-care providers in H hospital where he and 10 other persons
who had stayed on the 9th floor of the same hotel were admitted.
The ten guests who became infected in the MP hotel contributed
to spread the infection further to Vietnam, Canada, Singapore,
the US and various regions of China.
A male person (airport employee aged 26) who happened
to visit the MP hotel developed the disease and was admitted to
Prince Wales (PW) Hospital. A nosocomial infection developed and
also hit health-care providers, patients and visitors. Their number
reached 112. A male individual (33 years of age) who received
outpatient treatment in that hospital for kidney failure was one
of the victims. Then pneumonia infection spread suddenly in a
high-rise condominium (Amoy Garden Block E). In fact, 330 people
became infected. The source of infection was determined to be
the younger brother of a resident of Amoy Garden.
(Note - Superspreaders are known for spreading tuberculosis, smallpox,
staphylococcal infection, etc. Superinfectors, super shedders
and cloud cases are synonyms. The example of a hundred people
who contracted smallpox from individuals who traveled across England
by train in 1913 is famous.)
Vietnam F Hospital and Carlo Urbani
A businessman who was infected in Hong Kong
MP Hotel (US citizen, 48 years of age) contracted SARS on February
26 in Hanoi and was admitted to F Hospital. Twenty-two patients
developed influenza-like pneumonia inside this hospital until
March 20. The infection was also spreading similarly in Canada,
Singapore and in the United States. The WHO dispatched a physician
to F Hospital. He reported to the WHO that this pneumonia was
a "new type of pneumonia" different from the conventional type.
This is how an outbreak of infection with the new type of pneumonia
became known to the world. Unfortunately the doctor also contracted
the new type of pneumonia inside the hospital and passed away
on March 29. The victim was Dr.Carlo Urbani (46 years of age),
mentioned earlier in this article.
This new type of pneumonia is named SARS (Severe Acute
Respiratory Syndrome), and the virus at the origin of the disease
is called SARS virus. The world has been taking a high toll for
the control of the sickness.
Program of the symposium
Following the keynote report on SARS by Dr.
Chien-Jen Chan (Chairman of SARS, Taiwan), the current status
of SARS and the control measures, the laboratory test techniques,
the economic impact caused by the SARS epidemics and other topics
were discussed at the various sessions of the symposium.
Etiology, laboratory tests and epidemiology
The background leading to the identification
of coronavirus as the etiological agent, after going through the
Chlamydia hypothesis and the meta-pneumovirus hypothesis (Note:
about 8% isolated from specimens of patients afflicted with acute
respiratory infection. Paramyxovirus isolated from children with
pneumonia in Holland in 2002), was explained. (Note: coronavirus
was confirmed finally in infection experiments on monkeys. Significance
of monkey infection experiments: it is necessary to satisfy the
three Koch's postulates in order to establish a specified pathogen
as the etiological agent of a disease. Namely, 1) It must be isolated
from a high number of patients with the same disease; 2) it must
grow in pure culture; and 3) the same disease must be reproduced
when the microorganism is inoculated to healthy animals. However
these postulates can be applied in case of bacterial infections,
and the six Koch's postulates based on Rivers' revision are applied
in case of viral infections. Namely, 1) the microorganism must
be isolated from the infected host; 2) it must be cultured in
host cells; 3) it must be filterable; 4) a similar disease must
be reproduced in the host animals; 5) it must be re-isolated from
inoculated animals; and 6) the specific immune response to that
virus must be confirmed.)
Amongst the conditions for establishing that the isolated
coronavirus is the causal virus for SARS, 1) - 3) have already
been validated by several researchers. The veterinary medicine
research team of Erasmus Medical Centre in the Netherlands has
successfully reproduced a similar SARS infection in an infection
experiment with the virus isolated from cynomolgus monkeys. The
team also confirmed the re-isolation of the virus and the formation
of specific immunity. As a result, the theories of Chlamydia and
meta-pneumovirus were totally rejected. (Koch's postulates for
SARS virus; Fouchier RA et al., Nature, 2003, May 15, 423 (6937)
240: Department of Virology, Erasmus Medical Centre, 3015 DE Rotterdam,
The Netherlands.)
Virological studies have shown that FRhK-4 cells of
Rhesus monkey kidney origin exhibit a high susceptibility to SARS
virus and that these infected cells form a syncytium with fused
nuclei. Furthermore observation with the aid of the electronic
microscope has shown that the viral particles are released from
the cell surface and that they accumulate in the cytoplasm. The
release of SARS virus particles bore a close resemblance to the
budding pattern of paramyxovirus. In addition, the syncytium of
the infected Vero cells was similar to that of the paramyxovirus
including the measles virus.
Diagnosis and laboratory test techniques
a. Serological diagnosis: detection of SARS antibody
by ELISA or indirect fluorescent antibody technique.
b. Genetic diagnosis (RT-PCR technique): use of sense 5' TACACACCTCAGCGTTG
3' and antisense 5' CACCGAACGTGACGAAT 3'
as primers. These primers were utilized for gene detection on
23 specimens in total including nasopharynx specimens, urines
and feces of SARS patients in Amoy Garden.
Positive results were obtained in 11% in case of the urines and
in 94% in case of the feces. These results
underline the utility of feces specimens and of the RT-PCR technique
for the early diagnosis and the confirmation diagnosis. (Dr. Kwol
Yung Uuen, Dr. Ka Fai To) (Note: the WHO's SARS Research Network
is currently comparing and assessing the detection results
including seven primers and annealing conditions. At this point
of time, the detection rate for the genes by means of PCR is on
the order of 50%, and the risk of obtaining
false positive has also been pointed out.)
c. Virus isolation: patient specimens are inoculated into susceptible
cells such as Vero cells. This procedure is performed inside BSL-3
level laboratories.
Impact on the economy
The impact caused by the SARS epidemic upon
the economy translates currently into a 26% decrease in revenues
for the air travel business and a 23% falldown for the hotel business.
In the present context, a severe impact on the world economy is
feared. The necessity of working out and implementing SARS control
policies at the global level was stressed during the symposium
(Details omitted)
The SARS clinical profile progresses in three steps.
First stage: virus growth (seven days). Characteristic:
fever over 39C Second stage: immunological hypersensitivity (seven
days). Characteristics: new episode of fever and disorders of
the immune system Third stage: destruction of the lung functions
(seven days). Characteristics: decrease in the lung functions.
Approximately three weeks from the initial diagnosis (fever) to
death (Hong Kong)
Agents for treatment, antiviral agents
In the United States where no fatal cases
have been reported, antiviral agents are not employed for the
treatment of SARS. On the other hand, the fatality rate in Hong
Kong where antiviral agents are aggressively used is 15%. In the
views of the WHO, there exists as of now no effective treatment
agent.
Existence of atypical SARS
There exist patients presenting major symptoms
such as diarrhea instead of pneumonia. These cases may be diagnosed
with diseases other than SARS.
The approach in Vietnam
In Vietnam, 63 individuals have contracted
SARS so far, and five of them have passed away. Information on
SARS patients has been proactively published, hospitals specialized
in SARS have been set up and thorough measures have been taken
to isolate the patients and to disinfect the affected areas. This
country has successfully controlled SARS without causing panic
amid the public.
New zoonosis
The Chinese Ministry of Agriculture has announced
that the gene arrangement of the coronavirus isolated from masked
palm civets matched perfectly with the SARS virus, and suggested
that those animals were the source of infection. On the other
hand, there are also reports that the homology does not perfectly
match. Whether it is true or not that the source of infection
is masked palm civets, SARS is indubitably a new zoonosis.
Participation in the symposium
The power of transmission of SARS seems to
be weaker than that of measles or influenza. However its fatality
rate is high. In respect of social defense where no treatment
tools are available, SARS constitutes an extremely serious infectious
disease. (SARS has been designated as a new infectious disease
by the Ministry of Health, Labour and Welfare on April 3.) This
disease has flared up again in Taiwan, where it was supposed to
have been brought under control, and in Toronto. Disclosure of
information and early detection and isolation of patients are
indispensable to the control of SARS. Problems of human rights
are also involved in case of patient isolation. Nevertheless isolation
should be permitted as a matter of course for the protection of
the community and from the point of view of public hygiene. True
international cooperation free of political interference will
be necessary.
Fortunately enough Japan has not yet been afflicted
with SARS. Although there is still some concern regarding the
transportation system for SARS patients, preparations for laboratory
testing and isolation wards are ongoing. It will probably be possible
to contain secondary and tertiary infections, but a non-emotional
and prudent approach will be required.
This "silent war" caused by SARS, which has engendered
a three-month blank, is a challenge for humanity in that it lays
down the question of how measures for the control of infectious
diseases should be in the 21st century.
To conclude, I wish to extend my deep gratitude to
all the persons related to Interchange Association and to the
Ministry of Health, Labour and Welfare for having given me the
opportunity to attend the International Symposium on SARS Outbreaks.
|
| <
back |
INDEX
 |
Next
> |
|